These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37543629)

  • 61. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinically silent somatotropinomas may be biochemically active.
    Sakharova AA; Dimaraki EV; Chandler WF; Barkan AL
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2117-21. PubMed ID: 15671111
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases.
    He W; Yan L; Wang M; Li Q; He M; Ma Z; Ye Z; Zhang Q; Zhang Y; Qiao N; Lu Y; Ye H; Lu B; Shou X; Zhao Y; Li Y; Li S; Zhang Z; Shen M; Wang Y
    Endocrine; 2019 Jan; 63(1):27-35. PubMed ID: 30238327
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly.
    Biermasz NR; van Dulken H; Roelfsema F
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2476-82. PubMed ID: 10902796
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gamma knife radiosurgery for acromegaly--long-term experience.
    Jezková J; Marek J; Hána V; Krsek M; Weiss V; Vladyka V; Lisák R; Vymazal J; Pecen L
    Clin Endocrinol (Oxf); 2006 May; 64(5):588-95. PubMed ID: 16649981
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A rare case of acromegaly associated with pachydermoperiostosis.
    Shimizu C; Kubo M; Kijima H; Uematsu R; Sawamura Y; Ishizu A; Koike T
    J Endocrinol Invest; 1999 May; 22(5):386-9. PubMed ID: 10401713
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acromegaly associated with a granular cell tumor of the neurohypophysis: a clinical and histological study. Case report.
    Losa M; Saeger W; Mortini P; Pandolfi C; Terreni MR; Taccagni G; Giovanelli M
    J Neurosurg; 2000 Jul; 93(1):121-6. PubMed ID: 10883914
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Laboratory investigation of acromegaly: is basal or random GH > 0.4 µg/L in the presence of normal serum IGF-1 an important result?
    Rosario PW; Calsolari MR
    Arch Endocrinol Metab; 2015 Feb; 59(1):54-8. PubMed ID: 25926115
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance.
    Colao A; Pivonello R; Auriemma RS; De Martino MC; Bidlingmaier M; Briganti F; Tortora F; Burman P; Kourides IA; Strasburger CJ; Lombardi G
    Eur J Endocrinol; 2006 Mar; 154(3):467-77. PubMed ID: 16498061
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cabergoline therapy of growth hormone & growth hormone/prolactin secreting pituitary tumors.
    Freda PU; Reyes CM; Nuruzzaman AT; Sundeen RE; Khandji AG; Post KD
    Pituitary; 2004; 7(1):21-30. PubMed ID: 15638294
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center.
    Barrande G; Pittino-Lungo M; Coste J; Ponvert D; Bertagna X; Luton JP; Bertherat J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3779-85. PubMed ID: 11061538
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Short-term pre-surgical treatment with somatostatin analogues, octreotide and lanreotide, in acromegaly.
    Waśko R; Ruchała M; Sawicka J; Kotwicka M; Liebert W; Sowiński J
    J Endocrinol Invest; 2000 Jan; 23(1):12-8. PubMed ID: 10698045
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The common consensus criteria have high predictive values for long-term postoperative acromegaly remission.
    Kristof RA; Grote A; Redel L; Neuloh G; Klingmüller D; Schramm J
    Acta Neurochir (Wien); 2011 Jan; 153(1):19-25. PubMed ID: 20845050
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical and hormonal findings in patients presenting with high IGF-1 and growth hormone suppression after oral glucose load: a retrospective cohort study.
    Carosi G; Mangone A; Sala E; Del Sindaco G; Mungari R; Cremaschi A; Ferrante E; Arosio M; Mantovani G
    Eur J Endocrinol; 2021 Jul; 185(2):289-297. PubMed ID: 34081617
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A case of juvenile acromegaly that was initially diagnosed as severe congestive heart failure from acromegaly-induced dilated cardiomyopathy.
    Sue M; Yoshihara A; Okubo Y; Ishikawa M; Ando Y; Hiroi N; Shibuya K; Yoshino G
    Intern Med; 2010; 49(19):2117-21. PubMed ID: 20930439
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acromegaly with normal IGF-1 levels probably due to poorly controlled diabetes mellitus.
    Arihara Z; Sakurai K; Yamada S; Murakami O; Takahashi K
    Tohoku J Exp Med; 2008 Dec; 216(4):325-9. PubMed ID: 19060447
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acromegaly.
    Dineen R; Stewart PM; Sherlock M
    QJM; 2017 Jul; 110(7):411-420. PubMed ID: 26873451
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
    Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.